Socioeconomic costs of stroke in Korea: Estimated from the Korea national health insurance claims database

Seung Ji Lim, Han Joong Kim, Chung Mo Nam, Hoo Sun Chang, Young Hwa Jang, Sera Kim, Hye Young Kang

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Objectives : To estimate the annual socioeconomic costs of stroke in Korea in 2005 from a societal perspective. Methods : We identified those 20 years or older who had at least one national health insurance (NHI) claims record with a primary or a secondary diagnosis of stroke (ICD-10 codes: I60-I69, G45) in 2005. Direct medical costs of the stroke were measured from the NHI claims records. Direct non-medical costs were estimated as transportation costs incurred when visiting the hospitals. Indirect costs were defined as patients' and caregivers' productivity loss associated with office visits or hospitalization. Also, the costs of productivity loss due to premature death from stroke were calculated. Results : A total of 882,143 stroke patients were identified with prevalence for treatment of stroke at 2.44%. The total cost for the treatment of stroke in the nation was estimated to be 3,737 billion Korean won (KRW) which included direct costs at 1,130 billion KRW and indirect costs at 2,606 billion KRW. The per-capita cost of stroke was 3 million KRW for men and 2 million KRW for women. The total national spending for hemorrhagic and ischemic stroke was 1,323 billion KRW and 1,553 billion KRW, respectively, which together consisted of 77.0% of the total cost for stroke. Costs per patient for hemorrhagic and ischemic stroke were estimated at 6 million KRW and 2 million KRW, respectively. Conclusions : Stroke is a leading public health problem in Korea in terms of the economic burden. The indirect costs were identified as the largest component of the overall cost.

Original languageEnglish
Pages (from-to)251-260
Number of pages10
JournalJournal of Preventive Medicine and Public Health
Volume42
Issue number4
DOIs
Publication statusPublished - 2009 Jul 1

Fingerprint

National Health Programs
Korea
Stroke
Databases
Costs and Cost Analysis
International Classification of Diseases
Office Visits
Premature Mortality
Health Care Costs
Caregivers
Hospitalization
Public Health
Economics

All Science Journal Classification (ASJC) codes

  • Public Health, Environmental and Occupational Health

Cite this

Lim, Seung Ji ; Kim, Han Joong ; Nam, Chung Mo ; Chang, Hoo Sun ; Jang, Young Hwa ; Kim, Sera ; Kang, Hye Young. / Socioeconomic costs of stroke in Korea : Estimated from the Korea national health insurance claims database. In: Journal of Preventive Medicine and Public Health. 2009 ; Vol. 42, No. 4. pp. 251-260.
@article{453ff5e984554882a5574f1b3094aa5a,
title = "Socioeconomic costs of stroke in Korea: Estimated from the Korea national health insurance claims database",
abstract = "Objectives : To estimate the annual socioeconomic costs of stroke in Korea in 2005 from a societal perspective. Methods : We identified those 20 years or older who had at least one national health insurance (NHI) claims record with a primary or a secondary diagnosis of stroke (ICD-10 codes: I60-I69, G45) in 2005. Direct medical costs of the stroke were measured from the NHI claims records. Direct non-medical costs were estimated as transportation costs incurred when visiting the hospitals. Indirect costs were defined as patients' and caregivers' productivity loss associated with office visits or hospitalization. Also, the costs of productivity loss due to premature death from stroke were calculated. Results : A total of 882,143 stroke patients were identified with prevalence for treatment of stroke at 2.44{\%}. The total cost for the treatment of stroke in the nation was estimated to be 3,737 billion Korean won (KRW) which included direct costs at 1,130 billion KRW and indirect costs at 2,606 billion KRW. The per-capita cost of stroke was 3 million KRW for men and 2 million KRW for women. The total national spending for hemorrhagic and ischemic stroke was 1,323 billion KRW and 1,553 billion KRW, respectively, which together consisted of 77.0{\%} of the total cost for stroke. Costs per patient for hemorrhagic and ischemic stroke were estimated at 6 million KRW and 2 million KRW, respectively. Conclusions : Stroke is a leading public health problem in Korea in terms of the economic burden. The indirect costs were identified as the largest component of the overall cost.",
author = "Lim, {Seung Ji} and Kim, {Han Joong} and Nam, {Chung Mo} and Chang, {Hoo Sun} and Jang, {Young Hwa} and Sera Kim and Kang, {Hye Young}",
year = "2009",
month = "7",
day = "1",
doi = "10.3961/jpmph.2009.42.4.251",
language = "English",
volume = "42",
pages = "251--260",
journal = "Journal of Preventive Medicine and Public Health",
issn = "1975-8375",
publisher = "Korean Society for Preventive Medicine",
number = "4",

}

Socioeconomic costs of stroke in Korea : Estimated from the Korea national health insurance claims database. / Lim, Seung Ji; Kim, Han Joong; Nam, Chung Mo; Chang, Hoo Sun; Jang, Young Hwa; Kim, Sera; Kang, Hye Young.

In: Journal of Preventive Medicine and Public Health, Vol. 42, No. 4, 01.07.2009, p. 251-260.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Socioeconomic costs of stroke in Korea

T2 - Estimated from the Korea national health insurance claims database

AU - Lim, Seung Ji

AU - Kim, Han Joong

AU - Nam, Chung Mo

AU - Chang, Hoo Sun

AU - Jang, Young Hwa

AU - Kim, Sera

AU - Kang, Hye Young

PY - 2009/7/1

Y1 - 2009/7/1

N2 - Objectives : To estimate the annual socioeconomic costs of stroke in Korea in 2005 from a societal perspective. Methods : We identified those 20 years or older who had at least one national health insurance (NHI) claims record with a primary or a secondary diagnosis of stroke (ICD-10 codes: I60-I69, G45) in 2005. Direct medical costs of the stroke were measured from the NHI claims records. Direct non-medical costs were estimated as transportation costs incurred when visiting the hospitals. Indirect costs were defined as patients' and caregivers' productivity loss associated with office visits or hospitalization. Also, the costs of productivity loss due to premature death from stroke were calculated. Results : A total of 882,143 stroke patients were identified with prevalence for treatment of stroke at 2.44%. The total cost for the treatment of stroke in the nation was estimated to be 3,737 billion Korean won (KRW) which included direct costs at 1,130 billion KRW and indirect costs at 2,606 billion KRW. The per-capita cost of stroke was 3 million KRW for men and 2 million KRW for women. The total national spending for hemorrhagic and ischemic stroke was 1,323 billion KRW and 1,553 billion KRW, respectively, which together consisted of 77.0% of the total cost for stroke. Costs per patient for hemorrhagic and ischemic stroke were estimated at 6 million KRW and 2 million KRW, respectively. Conclusions : Stroke is a leading public health problem in Korea in terms of the economic burden. The indirect costs were identified as the largest component of the overall cost.

AB - Objectives : To estimate the annual socioeconomic costs of stroke in Korea in 2005 from a societal perspective. Methods : We identified those 20 years or older who had at least one national health insurance (NHI) claims record with a primary or a secondary diagnosis of stroke (ICD-10 codes: I60-I69, G45) in 2005. Direct medical costs of the stroke were measured from the NHI claims records. Direct non-medical costs were estimated as transportation costs incurred when visiting the hospitals. Indirect costs were defined as patients' and caregivers' productivity loss associated with office visits or hospitalization. Also, the costs of productivity loss due to premature death from stroke were calculated. Results : A total of 882,143 stroke patients were identified with prevalence for treatment of stroke at 2.44%. The total cost for the treatment of stroke in the nation was estimated to be 3,737 billion Korean won (KRW) which included direct costs at 1,130 billion KRW and indirect costs at 2,606 billion KRW. The per-capita cost of stroke was 3 million KRW for men and 2 million KRW for women. The total national spending for hemorrhagic and ischemic stroke was 1,323 billion KRW and 1,553 billion KRW, respectively, which together consisted of 77.0% of the total cost for stroke. Costs per patient for hemorrhagic and ischemic stroke were estimated at 6 million KRW and 2 million KRW, respectively. Conclusions : Stroke is a leading public health problem in Korea in terms of the economic burden. The indirect costs were identified as the largest component of the overall cost.

UR - http://www.scopus.com/inward/record.url?scp=77953654679&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953654679&partnerID=8YFLogxK

U2 - 10.3961/jpmph.2009.42.4.251

DO - 10.3961/jpmph.2009.42.4.251

M3 - Article

C2 - 19675402

AN - SCOPUS:77953654679

VL - 42

SP - 251

EP - 260

JO - Journal of Preventive Medicine and Public Health

JF - Journal of Preventive Medicine and Public Health

SN - 1975-8375

IS - 4

ER -